Zentalis Pharmaceuticals (ZNTL) has drawn fresh attention after selecting a 400 mg once-daily, 5-days-on, 2-days-off dose of azenosertib for Cyclin E1-positive platinum-resistant ovarian cancer, based ...
If you are wondering whether Viking Therapeutics at around US$34.26 is still offering value or is starting to look stretched, the next sections will walk through what the current price might be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results